.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Find suppliers and generic API sources
  • Identify first generic entrants

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Express Scripts
Deloitte
Queensland Health
McKesson
Cipla
UBS
Colorcon
Chubb
Medtronic
Moodys

Generated: June 23, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020120

« Back to Dashboard
NDA 020120 describes ALLERNAZE, which is a drug marketed by Lupin Atlantis and is included in one NDA. It is available from one supplier. Additional details are available on the ALLERNAZE profile page.

The generic ingredient in ALLERNAZE is triamcinolone acetonide. There are fifty drug master file entries for this compound. Eighty-two suppliers are listed for this compound. Additional details are available on the triamcinolone acetonide profile page.

Summary for NDA: 020120

Pharmacology for NDA: 020120

Suppliers and Packaging for NDA: 020120

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ALLERNAZE
triamcinolone acetonide
SPRAY, METERED;NASAL 020120 NDA Lupin Pharmaceuticals 27437-143 27437-143-01 15 mL in 1 BOTTLE, SPRAY (27437-143-01)

Summary for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:SPRAY, METERED;NASALStrength0.05MG/SPRAY
Approval Date:Feb 4, 2000TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

McKinsey
Farmers Insurance
Mallinckrodt
Moodys
Merck
Queensland Health
Novartis
Harvard Business School
Deloitte
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot